Finance

Lists
Why is ANRO up 2,17%?
Dive Deeper
ANRO:NYSE
Alto Neuroscience Inc
24,03 US$
+2,17%
(+0,51) 1D
24,03 US$
0,00% (0,00)
After hours
Closed: 8 ოქტ, 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANRO...
Open
23,03 US$
High
24,04 US$
Low
22,81 US$
Mkt. cap
942,99 მლნ.
Avg. vol.
562,00 ათ.
Volume
409,76 ათ.
52-wk high
37,48 US$
52-wk low
5,22 US$
EPS
-2,44 US$
Shares outstanding
39,24 მლნ.
No. of employees
68
Open
23,03 US$
High
24,04 US$
Low
22,81 US$
Mkt. cap
942,99 მლნ.
Avg. vol.
562,00 ათ.
Volume
409,76 ათ.
52-wk high
37,48 US$
52-wk low
5,22 US$
EPS
-2,44 US$
Shares outstanding
39,24 მლნ.
No. of employees
68
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
1 დღის წინ
Precision Trading with ANRO Group (ANRO) Risk Zones
About Alto Neuroscience Inc
CEO-
Employees68
Founded2019
Headquarters-
SectorPharmaceutical industry
Websitealtoneuroscience.com
Analyst ratings
Based on 5 analysts giving stock ratings to ANRO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ANRO in the last 3 months.
Highest
Current 24,03 US$
55,00 US$ (+128,88%)
Average
44,00 US$ (+83,10%)
Lowest
37,00 US$ (+53,97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Myles Minter
William Blair
Buy
Reiterated
-
-
10/02/2026
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
55,00 US$
+128,9%
09/21/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
-
-
08/14/2026
Andrew Tsai
Jefferies
Buy
Maintained
40,00 US$
+66,5%
08/13/2026
Thomas Shrader
BTIG
Buy
Reiterated
37,00 US$
+54%
08/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
44,00 US$
+83,1%
06/26/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
36,00 US$
+49,8%
05/18/2026
Laura Chico
Wedbush
Hold
Maintained
24,00 US$
-0,1%
05/14/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
30,00 US$
+24,8%
04/21/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
33,00 US$
+37,3%
04/02/2026
Last report
12 აგვ. 2026
Fiscal period
Q2 2026
-0,65 US$ / -0,77 US$
+15,95%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,52 მლნ.
12,00 მლნ.
20,29 მლნ.
22,11 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,43 მლნ.
5,06 მლნ.
6,84 მლნ.
7,02 მლნ.
Operating expense
14,95 მლნ.
17,06 მლნ.
27,14 მლნ.
29,13 მლნ.
Total operating expenses
14,95 მლნ.
17,06 მლნ.
27,14 მლნ.
29,13 მლნ.
Operating income
-14,95 მლნ.
-17,06 მლნ.
-27,14 მლნ.
-29,13 მლნ.
Other non operating income
-112,00 ათ.
-113,00 ათ.
-115,00 ათ.
-130,00 ათ.
EBT including unusual items
-14,18 მლნ.
-16,18 მლნ.
-26,24 მლნ.
-27,64 მლნ.
EBT excluding unusual items
-14,18 მლნ.
-16,18 მლნ.
-26,24 მლნ.
-27,64 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,18 მლნ.
-16,18 მლნ.
-26,24 მლნ.
-27,64 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,52
-0,45
-0,80
-0,65
Interest and investment income
1,53 მლნ.
1,56 მლნ.
1,56 მლნ.
2,11 მლნ.
Interest expense
-650,00 ათ.
-575,00 ათ.
-545,00 ათ.
-491,00 ათ.
Net interest expenses
882,00 ათ.
986,00 ათ.
1,02 მლნ.
1,62 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,79 მლნ.
-16,90 მლნ.
-26,95 მლნ.
-28,94 მლნ.
Gain or loss from assets sale
114,00 ათ.
-
9,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები